Search Results
Dr. Madduri on Eligibility for CAR T-Cell Therapy in Myeloma
Dr. Madduri on the Potential Impact of CAR T-Cell Therapy in Multiple Myeloma
Deepu Madduri, MD, on how CAR-T cell therapy plays a role in the management of multiple myeloma
Dr. Madduri on the Standard of Care for Transplant Eligible Patients With Myeloma
Deepu Madduri: An Emerging CAR T-Cell Therapy for Myeloma
Dr. Madduri on Treatment After CAR T Cells in Myeloma
Dr. Madduri on Challenges in Transplant-Eligible Patients With Myeloma
Biomarkers and patient eligibility for CAR T cell therapies in MM
Deepu Madduri, MD, explains how JNJ-4528 differs from other CAR-T products
Dr. Chari on Impact of CAR T Cells in Myeloma
Dr. Raje on the Rationale for CAR T-Cell Therapy in Multiple Myeloma
Dr. Vesole on the Advantages of CAR T-Cell Therapy in Multiple Myeloma
